News

Event
Partner
Milestone
Milestone
2020-06-04

ACT Genomics' Achievements In Precision Medicine Are Recognized By LDTS In Taiwan

LDTS registration proves that ACT Genomics provides reliable clinical genomic profiling results with clinical value, and this effort successfully allows many cancer patients to get better treatment opportunities through application for new therapies

Place:

Taipei

Milestone
2020-05-28

ACTGenomics is the first one to receive approval for laboratory-developed NGS tests and services (LDTS) in Taiwan

ACTGenomics performs high-quality sequencing services and ACTOnco® +、ACTDrug® +、ACTFusion™ 、ACTMonitor®Lung and ACTBRCA® / ACTBRCA® HRD are recognized by LDTS

Place:

Taiwan

Milestone
2020-04-07

ACT Genomics' TMB harmonization result is published in the Journal for Immunotherapy of Cancer

ACT Genomics is the only Asian genomic profiling company contributing to TMB harmonization in TMB project led by Friends of Cancer Research and our flagship panel, ACTOnco®+, shows the lowest variability in TMB comparison.

Place:

USA

Milestone
2020-03-03

ACTCerebra identifies targeted drug options for brain metastases

ACTCerebra, ACT Genomics’ latest genomic profiling service, sequences 40 druggable genes to create a new opportunity for physicians to identify the most effective targeted therapies based on past medical history.

Place:

Taiwan

Milestone
2019-12-10

ACT Genomics wins 2019 National Innovation Award

ACT Genomics’ ACTOnco®+ performs well and receives National Innovation Award, and is the only genomic profiling company receiving this honor in biopharma and precision medicine field.

Place:

Taipei

Milestone
2019-11-29

Congratulations! ACT Genomics wins the Golden Torch Award of ” Annual Top 10 Enterprise”

ACT Genomics won the award of “Annual Top 10 Best Enterprises” and the flagship product ACT Onco+ won the award of ”The Top 10 Best Products”

Place:

Taipei

Milestone
2019-07-18

ACT Genomics Wins Taiwan Bio Industry Organization Awards- Emerging Company of the Year

ACT Genomics drives innovation in global standard and individual markets, winning Taiwan Bio Industry Organization Awards- Emerging Company of the Year.

Place:

Taipei

Milestone
2019-07-05

ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park

ACT Genomics Holdings Co., Ltd, a leading cancer precision treatment solution provider, opened its third Next Generation Sequencing (“NGS”) laboratory in Asia at the Hong Kong Science Park, an innovation and technology centre spearheaded by HKSTP.

Place:

Hong Kong

Milestone
2019-04-19

ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

More precision cancer medicine are available for clinical needs and drug development in Japan! Find out more at the new analysis laboratory "Shonan iPark Laboratory" of ACTmed, a joint venture between Canon Medical Systems and ACT Genomics in Japan.

Place:

Japan

Milestone
2019-03-07

New Panel Launched: ACTBRCA HRD

ACTBRCA HRD is a new panel that sequences 48 genes including germline and somatic BRCA1/2, as well as other homologous recombination repair (HRR) genes, to assist physicians in identifying more patients for PARP inhibitors.

Place: